Clinical Trials Directory

Trials / Completed

CompletedNCT05123794

Shortened Depression Assessment Study

Using the Long to Short Approach to Develop Rapid Depressions Scales

Status
Completed
Phase
Study type
Observational
Enrollment
39,000 (actual)
Sponsor
University of Toronto · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

Participants will be asked to fill out an online questionnaire about their demographics information and all 42 items from the Depression Anxiety Stress Scale (DASS-42). A series of machine learning techniques will be applied to the dataset to develop a shortened assessment using the most important demographics and DASS-42 items from the original questionnaire, to predict depression levels indicated by DASS-42.

Detailed description

Clinical depression affects 5-10% of the world population each year and is a serious mental health issue globally. There are many traditional psychological scales that assess levels of depression in adults, where their items are often redundant in the information they carry, and their scoring is not necessarily linear to the item scores. Thus, machine learning techniques can help find the redundancy in the items, as well as the nonlinear relationship between the item scores and the final prediction. Using the Depression Anxiety Stress Scale 42 (DASS-42) as the basis, participants will be asked to fill out an online questionnaire about their demographics information (age, gender, country of residence, race, etc.) and all 42 items of DASS-42 to provide a dataset for this study. Feature selection techniques such as MRMR and Gini feature importance were applied to identify the most important features in the dataset. Then, using machine learning methods such as Logistic Regression, XGBoost, and Ensemble models, models will be fitted on the most important features to develop a shortened depression scale (7-9 items consisting of demographics items and DASS items) that accurately predicted the levels of depression (as measured by the AUC, ROC and F1 scores.

Conditions

Timeline

Start date
2019-09-01
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2021-11-17
Last updated
2023-12-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05123794. Inclusion in this directory is not an endorsement.

Shortened Depression Assessment Study (NCT05123794) · Clinical Trials Directory